Related by context. All words. (Click for frequent words.) 76 Mild cognitive impairment 70 Cognitive Impairment 68 amnestic MCI 68 Hyperlipidemia 67 Major Depressive Disorder 66 Gene Linked 65 amnestic mild cognitive impairment 65 Ischemic 65 Bronchiectasis 65 Growth Hormone Deficiency 65 Psychiatric Disorders 64 Diabetic Retinopathy 64 Cognitive Decline 64 Disease Progression 64 Metabolic Disorder 64 Generalized Anxiety Disorder 64 Ischemic Stroke 64 Atherosclerotic 64 Ischaemic 64 Secondary Hyperparathyroidism 64 Bipolar Depression 64 Alzheimer Disease AD 63 Rheumatoid Arthritis RA 63 Overactive Bladder 63 Frontotemporal Dementia 63 Comorbidities 63 Dyslipidemia 63 Critical Limb Ischemia CLI 63 Social Phobia 63 Nonalcoholic Fatty Liver Disease 63 Hypercholesterolemia 63 Parkinson Disease PD 63 Leukemias 63 Severe Primary IGFD 63 Panic Disorder 63 Chronic Myeloid Leukemia 63 Chronic lymphocytic leukemia 63 Major Depressive Disorder MDD 62 Protein Linked 62 Venous thromboembolism 62 Bipolar Mania 62 Gene Mutation 62 progressive neurodegenerative disorder 62 androgen deficiency 62 mycosis fungoides 62 Cutaneous T 62 Non Alcoholic Fatty 62 Diagnostic Criteria 62 nonalcoholic steatohepatitis 62 pulmonary hypertension PH 62 Chronic Myelogenous Leukemia 62 Beta Blockers 62 Schizoaffective Disorder 62 Heart Failure Patients 62 aMCI precursor 62 Vascular Dementia 62 Cognitive impairment 62 euthymic patients 62 Often Misdiagnosed 62 Bulimia Nervosa 62 Newly Diagnosed 62 Vertebral Fractures 62 Slows Progression 62 Comorbid 62 Slow Progression 62 Hyperkalemia 62 Advanced Melanoma 62 diabetes mellitus DM 62 Cognitive Problems 62 Improves Outcomes 62 Chronic Lymphocytic Leukemia CLL 62 juvenile idiopathic arthritis 62 Prediabetes 62 Myelofibrosis 62 Mood disorders 62 Parkinsonian Syndromes 62 Autoimmune Diseases 62 Novel Oral 62 Diabetic nephropathy 62 Retinopathy 61 Not Otherwise Specified 61 Juvenile Idiopathic Arthritis 61 Myelodysplastic Syndrome 61 Rheumatoid Arthritis Patients 61 Sleep Disturbances 61 mild cognitive impairment 61 cognitive dysfunctions 61 Cerebellar 61 Neovascular AMD 61 proliferative diabetic retinopathy 61 myelofibrosis polycythemia vera 61 Gene Variant 61 Myelodysplastic Syndromes 61 Obstructive Sleep Apnea 61 myeloproliferative neoplasms 61 Tasimelteon 61 Hypertriglyceridemia 61 Combination Treatment 61 induce orthostatic hypotension 61 Cell Lymphoma 61 vascular cognitive impairment 61 Alzheimer Dementia 61 secondary hyperparathyroidism 61 neuropsychiatric disorder 61 Social Anxiety Disorder 61 multi infarct dementia 61 Hippocampal 61 Diabetic Foot Ulcer 61 Low Testosterone 61 Idiopathic 61 atypical hemolytic uremic syndrome 61 comorbid anxiety 61 Alzheimer disease cognitive impairment 61 Diabetic Nephropathy 61 Autism Asperger Syndrome 61 ADPKD 61 Elderly Patients 61 proliferative retinopathy 61 mild cognitive impairments 61 Genetic Markers 61 Lowers Risk 61 generalized epilepsy 61 Non Alcoholic Steatohepatitis 61 Nilotinib 61 Enlarged Prostate 61 Tyrosine Kinase Inhibitors 61 idiopathic Parkinson disease 61 Cognitive Deficits 61 AA Amyloidosis 61 Fracture Risk 61 Chronic Insomnia 61 mild cognitive 61 neuropsychiatric symptoms 61 Systemic Sclerosis 61 1 diabetes T1D 61 Improve Survival 61 Metastatic Renal Cell Carcinoma 61 Inhaled Corticosteroids 61 Breast Cancers 61 Allergic Rhinitis 61 Benign Prostatic Hyperplasia 61 Osteopenia 61 Acute Coronary Syndromes ACS 61 Follicular Lymphoma 61 Ventricular Tachycardia 61 complement inhibitor eculizumab 61 Insulin Resistance 61 progressive dyspnea 61 neovascular 60 Cardiotoxicity 60 Autoimmune Disease 60 Hormone Refractory Prostate Cancer 60 Autoimmune Disorders 60 Laryngeal Cancer 60 Predict Risk 60 Orthostatic Hypotension 60 Critical Limb Ischemia 60 extrapyramidal symptoms 60 Stroke Risk 60 Acute Coronary Syndromes 60 Polyneuropathy 60 Namenda ® 60 Reduced Risk 60 T2DM 60 Gene Mutation Linked 60 Treating Chronic 60 Clinical Outcome 60 Eye Diseases 60 Mouse Model 60 ST Segment Elevation 60 Asthma COPD 60 Genes Identified 60 Antidepressants Linked 60 Thiazolidinediones 60 Neovascular Age Related Macular 60 Oral Fingolimod 60 Androgen 60 Autistic Disorder 60 Adenomas 60 Peripheral Artery Disease 60 cause cardiac channelopathies 60 pathological hallmark 60 primary hyperparathyroidism 60 Emerging Therapies 60 Minimally Invasive Treatment 60 myoclonus 60 Nocturia 60 Asymptomatic 60 mGluR2 NAM 60 Apolipoprotein E 60 memantine Namenda 60 schizophrenia CIAS 60 Drug Prevents 60 Breast Cancer Recurrence 60 Depressive Symptoms 60 Soft Tissue Sarcoma 60 Neovascularization 60 neurocognitive function 60 familial hypercholesterolemia 60 Esophagitis 60 Restless Legs Syndrome RLS 60 Genes Linked 60 NOMID 60 Hypertrophic 60 Beta Blocker 60 Functional Outcomes 60 Malignant Melanoma 60 Castration Resistant Prostate Cancer 60 Atypical Hemolytic Uremic Syndrome 60 Peripheral Arterial Disease 60 Unresectable 60 Papillary 60 PsA 60 familial amyloidotic polyneuropathy FAP 60 chronic renal disease 60 FDA Approves Drug 60 affective psychosis 60 Subtypes 60 Myopathy 60 Knee Osteoarthritis 60 neurologic disorder 60 Effective Treatments 60 cytopenias 60 Insulin Sensitivity 60 Parkinson disease multiple sclerosis 60 Hypogonadism 60 vWD 60 Treatment Resistant 60 Uncontrolled hypertension 60 Gene Variants 60 comorbid disorders 60 STRIDE PD 60 Acute Heart Failure 60 neuropathologic 60 Borderline Personality Disorder 60 Malignant Glioma 60 proliferator activated receptor 60 Short Stature 60 C Reactive Protein 60 Dilated Cardiomyopathy 60 Genetic Variations 60 Systemic Lupus Erythematosus SLE 60 Hypertrophy 60 Immune Cell 60 chronic myocardial ischemia 59 Rheumatoid 59 impaired cognition 59 Cholesterol Levels 59 Uterine Fibroids 59 Lupus Nephritis 59 Tyrosine Kinase Inhibitor 59 thrombocytosis 59 Prolongs Survival 59 neurobehavioral disorder 59 Brain Atrophy 59 Juvenile Idiopathic Arthritis JIA 59 Pelvic Organ Prolapse 59 mixed hyperlipidemia 59 Fibromyalgia Syndrome 59 Ovarian Cancer Patients 59 Treating Depression 59 Safinamide 59 Severe Asthma 59 Genes Predict 59 Pervasive Developmental Disorders 59 Non inferiority 59 Relapsing Multiple Sclerosis 59 Relapsed Refractory 59 Lewy bodies DLB 59 choroidal neovascularization 59 neurological disorder affecting 59 Hp2 2 59 Estrogen Receptor 59 Pediatric Patients 59 Prognostic Factors 59 Sjögren syndrome 59 systolic hypertension 59 Prostate Cancer Patients 59 Occlusive Disease 59 hyperprolactinemia 59 Acute Renal Failure 59 subclinical atherosclerosis 59 Renal Function 59 Acute Ischemic Stroke 59 Neurogenesis 59 Retinitis Pigmentosa RP 59 Left Ventricular 59 Drug Shows Promise 59 Arrhythmogenic 59 Early Diagnosis 59 Beta Amyloid 59 CP CPPS 59 Kidney Function 59 Aortic stenosis 59 Tiotropium 59 Gastrointestinal Stromal Tumors 59 Excessive Sleepiness 59 Hemolysis 59 Iron Deficiency 59 systemic autoimmune 59 Artery Disease 59 arterial calcification 59 essential thrombocythemia 59 HeFH 59 Malignancies 59 neurocognitive deficits 59 autonomic dysfunction 59 Muscle Wasting 59 Genetic Variation 59 Chronic Rhinosinusitis 59 Lymphocytic 59 hippocampal atrophy 59 Alzheimers Disease 59 Treatment Shows Promise 59 paroxysmal nocturnal hemoglobinuria 59 Prophylactic Treatment 59 Diabetic Macular Edema 59 Antiviral Therapy 59 hematopoietic cancers 59 renal artery stenosis 59 Improve Outcomes 59 Spasticity 59 medullary thyroid carcinoma 59 nonbacterial prostatitis 59 Kidney Failure 59 Decitabine 59 SHPT 59 Proliferative 59 Hepatic Encephalopathy 59 Gene Mutations 59 Genetic Variant 59 Alzheimer disease AD 59 transcranial Doppler ultrasound 59 subsyndromal 59 hyperhomocysteinemia 59 Intracerebral Hemorrhage 59 Research www. elsevier.com 59 Patients Undergoing 59 Comorbidity 59 chronic thromboembolic pulmonary 59 rheumatological 59 Systolic Hypertension 59 Treatable 59 Dupuytren Disease 59 Endometrial Cancer 59 moderate renal impairment 59 Alzheimer disease vascular dementia 59 Pervasive Developmental Disorder 59 Polymorphic Ventricular Tachycardia CPVT 59 Lewy Bodies 59 Risk Stratification 59 Urinary Incontinence 59 Myelodysplastic Syndrome MDS 59 Hyperactivity 59 white matter hyperintensities 59 Mitral Regurgitation 59 occlusion CRVO 59 Chronic Fatigue Syndrome CFS 59 Genes Associated 59 Aggressive Prostate Cancer 59 Refractory Angina 59 Brain Tumors 59 Shows Promise Against 59 lupus erythematosus 59 Renal Cell Carcinoma 59 narcolepsy cataplexy 59 Treatment Reduces 59 Metastatic Prostate Cancer 59 amnestic 59 comorbid depression 59 schizophrenia schizoaffective disorder 58 bacterial prostatitis 58 Epstein Barr Virus 58 Patients Suffering 58 Subarachnoid hemorrhage 58 Inflammatory Markers 58 atypical Hemolytic Uremic Syndrome 58 ACE Inhibitors 58 Trigeminal Neuralgia 58 artery stenosis 58 Prehypertension 58 Combo Therapy 58 AAT deficiency 58 Neural Stem Cells 58 elevated LDH 58 Depressive Disorder 58 CSF biomarkers 58 Ankylosing spondylitis 58 Polycythemia Vera 58 Cardiac Function 58 Fibromyalgia Pain 58 Chronic Lymphocytic Leukemia 58 Critical limb ischemia 58 Systemic lupus erythematosus SLE 58 cancer cachexia 58 Hepatocellular Carcinoma 58 familial adenomatous polyposis 58 Diabetic Patients 58 subclinical hypothyroidism 58 Obesity Linked 58 Brodmann Area 58 Age Related Macular 58 mania hypomania 58 Premenopausal Women 58 Autoantibodies 58 Resistant Hypertension 58 Chronic Pelvic Pain 58 dopaminergic therapy 58 hypochondriasis 58 HIV HCV coinfected 58 B Cell Lymphoma 58 Degenerative Disease 58 unstable angina UA 58 OSAHS 58 Diabetic neuropathy 58 hereditary degenerative 58 Blepharospasm 58 Hypoactive Sexual Desire Disorder 58 Chronic Constipation 58 Haptoglobin 58 prostate cancer CaP 58 Obstructive Sleep Apnea OSA 58 Diabetic Neuropathy 58 High Functioning Autism 58 Therapeutic Targets 58 chronic opioid 58 Behavioral Disorders 58 cognitive impairment 58 optic neuropathy 58 Squamous 58 ST Elevation Myocardial 58 hypometabolism 58 Melasma 58 neurocognitive impairment 58 Glucocorticoid 58 antiphospholipid syndrome 58 Invasive Breast Cancer 58 Paroxysmal Nocturnal Hemoglobinuria PNH 58 Diabetic Kidney Disease 58 Adenocarcinoma 58 Claudication 58 insulin resistance syndrome 58 Phase 2b Trial 58 erythematosus 58 Generalized anxiety disorder 58 Mitochondrial Dysfunction 58 Androgen Deprivation 58 Afib 58 Progenitor Cells 58 Cardiovascular Disease Risk 58 multisystem disease 58 Myocardial Ischemia 58 castrate resistant prostate cancer 58 TNF Blockers 58 Polycystic ovary syndrome PCOS 58 Keratitis 58 Subclinical 58 Therapy Improves 58 Lung Cancer Survival 58 Conduct Disorder 58 Irritable Bowel Syndrome IBS 58 Initiates Clinical Trial 58 phosphorylated tau 58 gastrointestinal dysfunction 58 Colorectal Adenomas 58 corticobasal degeneration 58 claudication 58 Helps Diagnose 58 Chronic Heart Failure 58 Migraine Headaches 58 ABCB1 58 Thyroid Cancer 58 Treated Patients 58 childhood disintegrative disorder 58 Esophageal Cancer 58 Signaling Pathway 58 Proves Effective 58 abdominal adiposity 58 Sezary syndrome 58 Chronic sinusitis 58 Lymphoid 58 Subgroup Analysis 58 Metastases 58 Sustained Reduction 58 Antigen Specific 58 Psoriatic arthritis 58 Atopic Dermatitis 58 levodopa therapy 58 Cognitive Function 58 Presbyopia 58 Neuroticism 58 Clinical manifestations 58 homozygous FH 58 Hyperplasia 58 Colorectal Cancers 58 Huntingtons disease 58 T1DM 58 Dyskinesia 58 Brain Scans 58 Acute Exacerbations 58 frontotemporal dementia FTD 58 Postmenopausal Women 58 Stress Induced 58 CYT# potent vascular disrupting 58 Advanced Renal Cell 58 debilitating neurodegenerative disorder 58 Antipsychotic Medications 58 bladder carcinoma 58 smoldering myeloma 58 autoimmune thyroiditis 58 Essential Tremor 58 bullous 58 Vascular dementia 58 diabetes dyslipidemia 58 systemic fungal infections 58 Arrhythmias 58 Hypertensive Patients 58 Wet AMD 58 Multiple Myeloma MM 58 Signaling Pathways 58 Hip Fractures 58 GI motility disorders 58 TTR amyloidosis 58 Interferon Beta 58 Hormone Therapy 58 Cognitive Disorders 58 Disord 58 hereditary predisposition 58 Fecal Incontinence 58 Blood Cancers 58 Central Retinal Vein 58 Valvular Heart Disease 58 Endothelial Function 58 Blood Pressure Drug 58 Subtype 58 leiomyomas 58 APOE e4 58 Major depressive disorder 58 Transcription Factor 58 Human Neural Stem 58 Meningiomas 58 vascular endothelial dysfunction 58 Parkinsonism 57 Gestational Diabetes 57 urothelial carcinoma 57 Brain Shrinkage 57 non alcoholic steatohepatitis 57 depression dysthymia 57 Idiopathic pulmonary fibrosis 57 GH deficiency 57 Investigational Treatment 57 nondemented 57 Hypotension 57 systemic amyloidosis 57 Bone Metastases 57 Critically Ill Patients 57 Benign Prostatic Hyperplasia BPH 57 Chronic Sinusitis 57 Hormone Replacement 57 Irritable Bowel 57 Clinical Trial Results 57 triiodothyronine 57 Previously Treated 57 Multiple Myeloma Patients 57 Abnormalities 57 Meta Analysis 57 Medulloblastoma 57 Glioma 57 Renal Anemia 57 Breast Tumors 57 Breast Cancer Metastasis 57 Chronic HCV 57 Etanercept 57 Gastroparesis 57 Fibroblast 57 Interstitial Cystitis 57 See CLINICAL PHARMACOLOGY 57 Disease Modification 57 Cardiac Resynchronization 57 dysthymic disorder 57 Hodgkin lymphoma HL 57 Severe Sepsis 57 Endothelial dysfunction 57 Myelodysplastic syndromes MDS 57 Microalbuminuria 57 Lipodystrophy 57 systemic lupus erythematosus 57 Neuroprotection 57 erythematosus SLE 57 Carcinoid Syndrome 57 Genetic Mutation 57 endoscopic ultrasonography 57 fibromyalgia syndrome 57 Alzheimer pathology 57 Diffuse Large B 57 Tumor Necrosis Factor 57 Testosterone deficiency 57 Angioedema 57 PAOD 57 giant cell arteritis 57 Lenalidomide 57 venlafaxine Effexor 57 psychiatric comorbidities 57 LHON 57 somatic symptoms 57 Hepatotoxicity 57 Inflammatory Diseases 57 Chronic Bronchitis 57 Amyloid 57 Proteinuria 57 Etiology 57 serum phosphate 57 glaucoma cataract 57 Thrombocytopenia 57 Sexual Desire 57 Venous Thrombosis 57 polyarticular 57 Chronic Prostatitis 57 pharmacologic treatments 57 HER2 overexpression 57 Cancer Treatments 57 incurable neurological disorder 57 Pharmacologic 57 Chronic ITP 57 neovascular form 57 Peripheral Vascular Disease 57 Adrenal 57 Enzyme Replacement Therapy 57 Obsessive compulsive disorder 57 Systemic lupus erythematosus 57 left ventricular diastolic 57 cortical atrophy 57 Iron Overload 57 metastatic neuroendocrine tumors 57 pathological hallmarks 57 Helps Predict 57 myelodysplastic syndrome MDS 57 Pulmonary Arterial Hypertension 57 Acute myeloid leukemia 57 Syncria R 57 primary Restless Legs 57 Genetic Marker 57 Metabolic Disease 57 ceroid lipofuscinosis NCL 57 Suicidal Ideation 57 unfavorable cytogenetics 57 Non Invasive Treatment 57 Smoking Linked 57 hypercoagulable 57 diabetic kidney 57 Neurodegenerative 57 Hypothyroidism 57 Diastolic Heart Failure 57 myeloproliferative diseases 57 Psychotic Disorders 57 Colon Polyps 57 Cholangiocarcinoma 57 thyroid dysfunction 57 Node Positive 57 Statin Drugs 57 Chronic Inflammatory Demyelinating Polyneuropathy 57 Breast Cancer Patients 57 paragangliomas 57 comorbid conditions 57 hypovitaminosis D 57 Sleep disordered breathing 57 Carcinoid tumors 57 Sjogren Syndrome 57 alexithymia 57 Brain Lesions 57 proton MR spectroscopy 57 premorbid 57 INVEGA ® 57 frontotemporal dementia 57 psoriatic arthritis PsA 57 Anxiety Depression 57 Mucositis 57 Myeloproliferative 57 hematological abnormalities 57 Lung Cancers 57 systemic juvenile idiopathic 57 Stem Cell Treatment 57 Generalized Anxiety Disorder GAD 57 NPM1 mutation 57 immunodeficiencies 57 Antidepressant Use 57 Organ Rejection 57 extrapyramidal symptoms EPS 57 Cognitive Dysfunction 57 transthyretin amyloidosis 57 #:#-#,# CrossRef Medline [001] 57 Cardiovascular Risk 57 Alternative Treatments 57 Male Pattern Baldness 57 Menopausal Women 57 APOE genotype 57 Epilepsy Drug 57 Bone Fractures 57 Therapy Shows Promise 57 Sexual Function 57 Neuropathic 57 Ischemia 57 Skin Cancers 57 Retreatment 57 Lung Function 57 Stomach Cancer 57 Sarcopenia 57 lactate dehydrogenase LDH 57 hyperphenylalaninemia HPA due 57 Eisenmenger syndrome 57 IBS C 57 Genetic Mutations 57 Adrenal Fatigue 57 anemias 57 thyrotropin levels 57 Post Operative 57 pathologic myopia 57 Sensory Integration Disorder 57 Natalizumab 57 Ankylosing Spondylitis 57 Immunologic 57 Phase Ib Clinical Trial 57 dysplastic nevi 57 pathophysiological mechanisms 57 Interstitial cystitis 57 Carcinomas 57 Male Infertility 57 Pulmonary Arterial Hypertension PAH 57 Randomized Study 57 Related Dementia 57 cognitively normal 57 Impaired glucose tolerance 57 Treating Heart Failure 57 Premature Aging 57 Anaplastic 57 Skeletal Muscle 57 thyrotropin 57 polymyalgia rheumatica 57 Glucose Metabolism 57 seminomas 57 Acute Decompensated Heart Failure 57 Severe Acne 57 fronto temporal dementia 57 Vulnerable Plaque 57 Reflux Disease 57 autoimmune thyroid 57 Differential Diagnosis 57 Von Willebrand disease 57 disease NAFLD 57 Anxiety disorders 57 constipation predominant irritable bowel 57 hypoparathyroidism 57 dermatologic reactions 57 Interpersonal Psychotherapy 57 Appears Safe 57 hyperglycaemia 56 Rare Genetic 56 Prospective Randomized 56 atherogenic dyslipidemia 56 INCB# [003] 56 psychosocial functioning 56 AAT Deficiency 56 Ranibizumab 56 Hyperparathyroidism 56 neurocognitive disorder 56 Osteoporosis Drugs 56 Fabry Disease 56 mental retardation epilepsy 56 Andropause 56 Leber Congenital Amaurosis LCA 56 EXJADE 56 Sipuleucel T 56 nonalcoholic steatohepatitis NASH 56 severe malignant osteopetrosis 56 Alzheimer dementia 56 Adolescent Depression 56 Sclerosis 56 oligodendrogliomas 56 menopause andropause 56 Autistic Spectrum Disorders 56 Ventricular Arrhythmias 56 Cholesterol Linked 56 progressive neurodegenerative 56 myofascial pain syndrome 56 Efficacious 56 astrocytomas 56 Fungal Infections 56 affective disorders 56 cell lymphoma CTCL 56 haematologic 56 prostate cancer PCa 56 Viral Infections 56 Innate Immune 56 Inflammatory Bowel Diseases 56 Excessive daytime sleepiness 56 arterial thickening 56 Glioblastoma Multiforme 56 Inflammatory Bowel Disease 56 Kinase Inhibitors 56 Renal Failure 56 Acute myeloid leukemia AML 56 C1 INH deficiency 56 geographic atrophy 56 Acute Coronary Syndrome 56 Nonspecific 56 premenstrual dysphoric disorder PMDD 56 Treating Prostate Cancer 56 Adult Onset 56 NASH Huntington 56 5 HT6 receptor 56 TPMT 56 progressive degenerative 56 Dementia Patients 56 dyskeratosis congenita 56 Gene Variation 56 Hemorrhagic Stroke 56 Thrombolysis 56 Obese Patients 56 Device Helps 56 overt nephropathy 56 Bullous 56 kidney urologic 56 autosomal dominant polycystic kidney 56 Contrast Agent 56 hypothalamic pituitary adrenal axis 56 prematurity Stargardt disease 56 Migraine Headache 56 Colorectal Cancer Risk 56 underlying vasculopathy 56 Adenoma 56 Neurocognitive 56 induced macular edema 56 Chronic Renal Failure 56 neuro degenerative disorder 56 AMD diabetic retinopathy 56 myeloproliferative disorders 56 #:#-#,# CrossRef Medline [002] 56 Non Inferiority 56 Coronary Disease 56 FTLD 56 affective psychoses 56 Clusterin 56 Intraocular Pressure 56 anorexia nervosa bulimia nervosa 56 Long Term Outcomes 56 Respiratory Distress 56 myocardial infarction ventricular fibrillation 56 Serious Infections 56 Septic Shock 56 circadian genes 56 malignant pleural effusion 56 Sleep Duration 56 asymptomatic carotid stenosis 56 homozygous familial hypercholesterolemia 56 preserved ejection fraction 56 leukemia AML 56 hypokalemia hypomagnesemia 56 treat benign prostatic 56 carcinoid tumors 56 Prostatic 56 purpura ITP 56 alpha1 antitrypsin deficiency 56 Vertebral Compression Fractures 56 Nonalcoholic Steatohepatitis 56 neurosensory 56 Gastroesophageal Reflux Disease 56 Dissociation 56 Atopic dermatitis 56 Kidney Stones 56 overactive bladder syndrome 56 Lateral Sclerosis 56 Migraine Pain 56 Neurodegenerative diseases 56 Lung Cancer Patients 56 elevated triglyceride levels 56 systemic lupus erythematosus SLE 56 neurological abnormalities 56 carotid atherosclerosis 56 Lymphocyte 56 2 diabetes T2D 56 Cardiovascular Events 56 Anti VEGF 56 #q# deletion syndrome 56 intermittent claudication 56 Chronic pancreatitis 56 Pseudobulbar affect PBA 56 Anticoagulants 56 Seasonal Allergic Rhinitis 56 idiopathic thrombocytopenic purpura 56 abnormal genital 56 Endothelial 56 Benign prostatic hyperplasia BPH 56 Korsakoff syndrome 56 anticholinergic agents 56 Chemotherapy induced 56 Mental Illnesses 56 depressive symptomatology 56 Advanced Prostate Cancer 56 Cancer Cachexia 56 Cytotoxicity 56 Prodarsan R 56 macular degeneration AMD 56 anticholinergic medications 56 Female Sexual Dysfunction 56 neuronal dysfunction 56 Chronic Hepatitis B 56 relapsing remitting MS RRMS 56 Predict Prostate Cancer 56 silent myocardial ischemia 56 vascular occlusive diseases 56 Diabetic Foot Ulcers 56 Atopic eczema 56 Mantle Cell Lymphoma 56 Chronic Lyme Disease 56 MALT lymphoma 56 muscular dystrophy cystic fibrosis 56 Peripheral Arterial 56 Renal Cancer 56 tryptophan depletion 56 onset diabetes mellitus 56 Bipolar Disorder 56 Diabetic Neuropathic Pain 56 androgen deprivation 56 Epidermal Growth Factor Receptor 56 Myoblast 56 inherited neurological disorder 56 Periodontitis 56 Chronic Inflammatory 56 Neurogenic 56 Esophageal 56 Aurora Kinase 56 Genes Discovered 56 Acute Myocardial Infarction 56 dual endothelin receptor antagonist 56 MELAS syndrome 56 Systemic Lupus Erythematosus 56 histological subtype 56 vulvovaginal atrophy 56 LQTS 56 Chronic Wounds 56 Immune Responses 56 EECP R 56 nortriptyline Pamelor 56 migraines neurorehabilitation 56 Interpersonal psychotherapy 56 Renal Disease 56 HIV lipodystrophy 56 Homeostasis 56 Cholinesterase inhibitors 56 Antisocial Personality Disorder 56 Eye Disease 56 Donepezil 56 Electrical Stimulation 56 Unstable angina 56 Iron Deficiency Anemia 56 recurrent glioblastoma multiforme 56 parkinsonian 56 HNPCC 56 cognitive impairment associated 56 Virus Linked 56 Test Detects 56 Successfully Treated 56 Sleep Disordered Breathing 56 adjuvant systemic 56 Carcinoma 56 coronary revascularization procedures 56 colorectal carcinoma 56 Suicidal Behavior 56 Peritoneal Mesothelioma 56 Spectrum Disorders 56 BRCA1 BRCA2 56 Symptom Scale 56 Chronic Stress 56 Anxiety Disorders 56 bronchogenic carcinoma 56 Neuropsychiatric 56 Wernicke Korsakoff syndrome 56 cancerous enlargement 56 Depressive Disorders 56 Acute Coronary 56 Placebo Controlled Study 56 relapsed MM 56 Thyroid Disease 56 Predisposition 56 Moderate Drinking 56 demyelinating 56 davunetide intravenous AL 56 Primary IGFD 56 histologic subtype 56 Mimetics 56 Exacerbation 56 polycythemia vera essential thrombocythemia 56 Gastric Cancer 56 Chronic Cough 56 Epileptic Seizures 56 IPAH 56 Genetic variants 56 Chronic Kidney Disease 56 hypoperfusion